ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Elham Yaaghubi, a fifth-year PhD candidate in the Castellano Lab at the University of Florida, let her column chromatography fractions sit overnight. When she returned to the lab, she saw that the solvent had continued to evaporate, causing her compound to form these fireworks-like crystals in the test tubes. “As soon as I saw it, I learned that the column chromatography was successful, and the fractions came out super pure with a good yield, which paves the road for the final step in my synthetic pathway!” Yaaghubi says. The compound shown here is a synthetic intermediate in the pathway toward a proprietary compound her group hopes will have exciting anticancer activity. Yaaghubi’s group is working to develop a new family of small molecules to treat aggressive forms of breast cancer.
Submitted by Elham Yaaghubi
Do science. Take pictures. Win money. Enter our photo contest here.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter